Top

European Journal of Pediatrics

Published in:

01-06-2011 | Correspondence

Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended

Authors: Patrizia D’Eufemia, Mauro Celli, Martina Tetti, Roberto Finocchiaro

Published in: European Journal of Pediatrics | Issue 6/2011

Excerpt

Sir, …

El-Karaksy H, Rashed M, El-Sayed R, El-Raziky M, El-Koofy N, El-Hawary M, Al-Dirbashi O (2010) NTBC therapy for tyrosinemia type 1: how much is enough? Eur J Pediatr 169:689–693PubMedCrossRef

Holme E, Lindstedt S (1998) Tyrosinaemia type 1 and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione). J Inherit Metab Dis 21:507–517PubMedCrossRef

Title: Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended
Authors: Patrizia D’Eufemia
Mauro Celli
Martina Tetti
Roberto Finocchiaro
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: European Journal of Pediatrics / Issue 6/2011
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-011-1419-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

A child with mental retardation and asymmetrical hypertrophy of limbs

Diagnosis of a trend towards obesity in preschool children: a longitudinal study

Eponym

HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland

Neurological complications of pandemic influenza (H1N1) in children

Comparison of several anthropometric indices with insulin resistance proxy measures among European adolescents: The Helena Study